Hospitals and cancer centers are running out of two major injectable cancer drugs: carboplatin and cisplatin. Dr. Eleonora Teplinsky, head of breast medical oncology for the Valley Health System in New Jersey, joins Ali Rogin to discuss the causes and effects of the shortages, and the dilemmas that providers and their patients now face.
Leave a reply